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ABSTRACT
Aspergillus fumigatus is a fungus found ubiquitously in the environment including in the air we
breathe. Though not a threat to most people, immunodeficient or immunosuppressed individuals
are at risk for developing severe infection, including the life-threatening condition of invasive
aspergillosis. The hematopoietic cell specific GTPase protein Rac2 is associated with major roles
in innate immune defense. Currently Rac2 has been demonstrated to be crucial for survival
against a variety of infections. Here, we use a rac2 null mutant zebrafish line and morpholino
approaches to elucidate roles of Rac2 in mounting the macrophage host defense response against
A. fumigatus infection. Zebrafish provide an optimal model for studying host-pathogen
interactions due to high compatibility with in vivo imaging techniques. Data demonstrates
significantly impaired survival in zebrafish lacking Rac2 expression during A. fumigatus
infection. In this infection, I have found that absence of Rac2 results in no impairment to
macrophage migration or phagocytosis. Despite this apparent lack in major involvement of Rac2
in early macrophage response, I demonstrate that rac2 null mutants are characterized by
significant impairment in ability to suppress germination, highlighting an important role for Rac2
in promoting the germination inhibiting activity of macrophages.
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INTRODUCTION
1.1 Aspergillus fumigatus
1.1.1 Invasive aspergillosis and clinical significance
Aspergillus fumigatus is one of the primary causes of fungal infection in humans, particularly in
immunocompromised patients1. Infection in the immunocompromised may result in invasive
aspergillosis (IA), one of the most severe forms of fungal infection. Infections may occur as a
complication of surgery and/or immunosuppressive treatment and subsequent inhalation of
airborne A. fumigatus spores. Immunosuppressed patients with neutropenia were previously the
main risk group for acquiring severe A. fumigatus infection however infections in nonneutropenic patients have been increasing, with additional underlying diseases or structural lung
damage1 being found to substantially increase risk of acquiring serious infection2,3. A form of A.
fumigatus infection called Allergic Bronchopulmonary Aspergillosis (ABPA) is primarily
diagnosed in patients with cystic fibrosis4, highlighting the risk posed by underlying structural
lung disease and the ability of A. fumigatus to take advantage of this environment.

Timely treatment of IA in patients is critical to outcome, however due to rapid onset and
similarity of symptoms to other more common infections such as tuberculosis, a high index of
suspicion is required in individuals without any well-defined risk factors3. These contribute to
high mortality rates and hospital costs among Intensive Care Unit (ICU) patients5. The size of the
immunosuppressed risk group is increasing as more chemotherapeutic treatments, surgeries, and
hospital advancements continue. Despite advancements in development of anti-fungal medicines,
deaths caused by IA are increasing, largely due to the unchanging high mortality rate paired with
an increasing amount of patients undergoing immunosuppression for hospital procedures5,6.
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1.1.2. A. fumigatus life cycle
A. fumigatus is recognized as an important cause of disease among the immunosuppressed,
however colonization in a human host occurs only opportunistically provided the immune system
is sufficiently suppressed. This saprotrophic fungus predominantly exists as a soil microbe and is
found ubiquitously in the environment. Dispersion and spread of A. fumigatus occurs when
asexual spores become airborne and are carried by winds to new locations in the environment.
Due to the airborne nature of these spores, they are also commonly found in indoor environments
including the air, where they may be inhaled unknowingly by an individual7,8. As this is a
saprotrophic fungus, it preferentially grows on decaying organic matter, where it partakes in the
important ecological roles of carbon and nitrogen fixation7,8.

Like many fungi, A. fumigatus undergoes asexual reproduction. Though sexual reproduction
occurs with this species in nature, asexual reproduction especially in a living host is thought to
be far more likely due to observations that sexual reproduction requires two strains of opposing
mating types. Given the capability for asexual reproduction, large (~30Mb) genome size, and
high output of 104 asexual spores per spore head, it is unsurprising that A. fumigatus has a
propensity for acquiring de novo mutations rapidly, some of which have/can include resistance to
azoles9,10.

Asexual reproduction of A. fumigatus begins with a single spore. Upon suitability of conditions
which include appropriate temperature and nutrient availability, the spore will begin to swell, a
behavior preceding germination. The swollen spore forms a short hyphal growth, which has a
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branch like structure appearance. Through continual mitotic division, this hyphal growth forms
branches and multiple projections called hyphae. This collective growth of branches is referred
to as a mycelial network. From the mycelial network, conidiophores develop. It is these
conidiophores which are responsible for dispersion of asexual spores and continuation of the A.
fumigatus lifecycle. It is also during the dispersion of airborne asexual spores that chances for
opportunistic infection in humans occurs, as these spores are carried by winds and are capable of
germinating in the lung environment of the immuno-susceptible9 (Fig. 1)

Figure 1 Asexual lifecycle of Aspergillus fumigatus (Made using Biorender)

1.1.3. A. fumigatus pathogenicity and disease spectrum
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The pathogenesis of A. fumigatus is highly reliant on the immune status of the host. This is
especially implicated due to the nature of the risk groups, which are comprised of individuals
with varying degrees of immunodeficiency with neutropenia being an extreme, and treatment
related immunosuppression becoming increasingly more common3. Though A. fumigatus is
known to cause a range of diseases resulting from infection in the lungs, the initial establishment
of infection follows a similar pattern. Early stages of pathogenesis begin when an individual’s
immune system is unable to rapidly clear inhaled spores which have contacted alveolar tissue
and other lung parenchyma. Germination ability/efficiency is a key feature in pathogenesis
establishing factors of A. fumigatus, with more rapidly germinating strain CEA10 shown to
induce greater inflammation and damage than slower germinating strain Af29311. Adaptation to a
low nutrient and hypoxic environment are also required for initial pathogenesis12–14. Upon
germinating, lack of fungal clearance due to immunodeficiency allows aggregations of fungal
hyphae to form; These rounded dense collections of hyphal growth, mucus, and cellular debris
are termed aspergillomas3,7 (Fig. 2). These aspergillomas are a consistent feature chronic and/or
severe diseases caused by A. fumigatus including: ABPA, Chronic pulmonary aspergillosis
(CPA), and IA. Once formed, aspergillomas allow A. fumigatus to persist in the host
environment because they possess and secrete extrapolymeric substances (EPS) to attach to
epithelial cells and effectively create a biofilm7,8,12, presenting an additional challenge for antifungal medicines to penetrate. Notably, aspergillomas do not invade lung tissue nor spread from
the lungs in CPA and ABPA and are thus considered localized chronic infections.
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Invasive Aspergillosis is the most severe form of infection as it has progressed from a localized
infection. It is characterized by hyphal invasion of host tissue. Production of host tissue

Figure 2 Example of an aspergilloma (Created using Biorender)
degradative enzymes by these hyphae are a major source of host damage sustained. Pulmonary
Invasive Aspergillosis (PIA) is the most common form of IA and consists of invasive A.
fumigatus infection which has not progressed beyond the lungs. This invasive spread is achieved
through invasion of host pulmonary epithelial cells. Once adhered, conidia are able to induce
endocytosis15 and a portion of hyphae are able to escape non-acidified phagolysosomes,
proceeding to invade deeper tissue16. Hyphae which have invaded and emerge from endothelial
tissue proceed to angioinvasion. Thrombosis will typically occur, blocking dissemination of
hyphae in the bloodstream. In particularly immuno-impaired individuals, thrombosis may not
occur which leads to acute invasive aspergillosis, a systemic infection and considered the most
severe fungal infection for the immunosuppressed17 (Fig. 3). In this disease hyphae, typically in
11

smaller fragments, undergo hematogenous spread to other organs17 which include the kidneys,
heart, brain, and uncommonly other areas including the peritoneum, liver, or gastrointestinal
system.

Figure 3 Aspergillus fumigatus pathogenesis in invasive aspergillosis and distinctions
between pulmonary and systemic forms: 1 conidium adheres to alveolar epithelial cell
membrane and induces endocytosis. 2 intracellular germination allows some hyphae to escape
phagolysosome maturation and spread to endothelial cells 3 endothelial invasion allows hyphae
to access blood vessels 4 (Pulmonary) Host thrombus prevents hematogenous spread of hyphae 4
(Acute) In extremely immuno-impaired hosts thrombus formation may be impaired, allowing
hyphae to break off into the bloodstream 5 Hyphal fragments are carried to additional
sites/organs consequentially resulting in a systemic infection. (Created using Biorender)
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1.2 Current Treatments for Aspergillosis
1.2.1. Current treatment practices and outcomes
Current treatments for Invasive Aspergillosis patients remain limited to anti-fungal therapy.
Mold-active triazoles represent the primary class of anti-fungal drugs in use as a first-line
therapy option in treating IA, although amphotericin B of the polyene class of anti-fungal drugs
is often an alternative therapy19–21. Voriconazole was approved for use as primary therapy in
treating IA in 2002, and is still the most common first-line therapy to date19. Voriconazole

Figure 4 General modes of action for antifungal drugs Published in Donnelly et al 21

achieves its antifungal effects by inhibiting the fungal enzyme 14a-sterol demethylase. This
prevents de-methylation of lanosterol from occurring thus disrupting ergosterol synthesis.
Accumulation of these methylsterols prevent fungal cell growth and replication from
continuing21 (Fig. 4).
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Voriconazole is rapidly absorbed within 2hrs when taken in oral form and is characterized by
high bioavailability. Intravenous and oral administration is thus used as necessary, with regimens
lasting anywhere between 9-24 weeks. Clinical studies have repeatedly demonstrated
significantly improved survival in patients treated with voriconazole, particularly as immediate
first-line therapy. In a direct comparison of voriconazole to amphotericin B, an alternative,
voriconazole treatment resulted in a successful treatment outcome for 52%, versus 31.6% of
patients treated with amphotericin B20. Additionally, voriconazole also seems to consistently
cause fewer side effects in patients20,23.

1.2.2. Limitations of anti-fungal therapy
Other Anti-fungal drugs active against IA perform worse or match the efficacy of voriconazole at
best. Despite the first-line therapy status of voriconazole, this treatment is failing in 40-70% of
patients many of which die within 1 year of clearing hospitalization, or in cases with shorter (9
week regimens) having IA relapse following voriconazole treatment 23–27. The difficulty of
treating IA is reflected in the population this disease affects. Most patients suffering from this
disease have underlying diseases and/or immunodeficiencies which have allowed for severe
fungal infection to occur. Because such patients are often hematopoietic cell or organ transplant
recipients, immune status is fragile26,27. There is also high risk for concomitant medication drug
interactions to voriconazole, which is known to interact with an extensive amount of drugs22.
Severe side effects seem to consistently occur in several patients, typically presenting as acute
renal failure, especially in response to intravenous administration21. A clinical study with a focus
on treatment related adverse events (AE) of voriconazole found that 22 patients (18.5%) had to
discontinue use of voriconazole, all due to treatment related AEs23. Drug monitoring is usually
14

necessary, particularly during initial treatment of IA. Achieving steady-state pharmacokinetics
has been reported to take 5-7 days28,29, confounding the need immediately treat this rapid
infection. A clinical study focusing on drug monitoring found that concomitant medications
including glucocorticoids and proton pump inhibitors significantly affect the trough (lowest)
level of voriconazole in patient serum as does the patients CYP2C19 (liver enzyme) genotype26.
Intra and inter-patient serum level variation demonstrated in this clinical study highlights that
voriconazole follows non-linear pharmacokinetics in adults, adding an additional hurdle to
proper treatment as variation in dosing will compound difficulty in predicting patient outcome of
voriconazole therapy.

Figure 5 Aspergillus fumigatus azole resistance (reported in red countries) Published in Linden
et al 30

Azole resistant strains of Aspergillus fumigatus have been identified across the globe (Fig. 5).
This resistance is acquired through either use of azoles in fungicides or azoles in clinical
settings30. Azole resistant A. fumigatus has been detected in ~7% of culture-positive patients with
trends increasing in 2014-2015, as reported by some medical centers30. Though anti-fungal
15

resistant strains of A. fumigatus are currently of minor relevance, it is yet another factor of
uncertainty affecting the current treatment of IA on a measurable level.

1.2.3. Potential of immunotherapy
Immunotherapy is already used in treatment of various forms of cancer; however, it is
increasingly broadening in application toward treatment of infectious diseases as well.
Immunotherapy represents an innovative alternative treatment which also combats antimicrobial
resistance31. Immunotherapies used to treat cancer are effective in part due to their ability to
boost immune defenses in cancer patients, which are often immunocompromised. The
immunocompromised/immunosuppressed form the majority of individuals at high risk for
contracting invasive aspergillosis. This is largely due to a sub-optimal innate immune response,
allowing Aspergillus fumigatus to undergo rapid spread of invasive infection. In vivo studies
highlight that at least some immune function is critical to delay pathogenesis and allow currently
used treatments including voriconazole to work optimally32,33. The importance of rapid host
immune defense in outcome of this infection is critical as A. fumigatus has been shown to
progress to invasive hyphae within only 96 hours in an immunosuppressed mammalian model 33
(Fig. 6). A rapid host response involving resident macrophages is particularly linked to
suppression of fungal germination, which delays A. fumigatus pathogenesis, buying time for
additional host defense and/or for antifungal treatments to gain efficacy32,34. The
immunodeficient nature of the risk groups and rapid pathogenesis involved in invasive
aspergillosis indicate that immunotherapy may be an effective alternative and/or combinatorial
therapeutic option for existing anti-fungal treatments for this disease.
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Figure 6 Aspergillus fumigatus histological analysis of pathogenesis during the initial 96
hours of infection. A. fumigatus (in black) is seen invading lung tissue (in blue) in an
immunosuppressed rabbit model33. Published in Hope et al 201033
1.3 The Innate Immune System Response
1.3.1 The innate immune system response to invasive aspergillosis
The innate immune response to A. fumigatus begins rapidly following contact of inhaled spores
with respiratory epithelial cells and alveolar macrophages, which already reside at possible
infection sites. Though respiratory epithelial cells can produce anti-microbial peptides, they are
not professional phagocytes, and are less capable of killing internalized fungal spores compared
17

to the alveolar macrophage. Pattern recognition receptors (PRRs) such as C-type Lectin
Receptors (CLR) and Toll-like Receptors (TLRs), which recognize fungal pathogen associated
molecular patterns (PAMPs) such as β-glucan. Resident alveolar macrophages act rapidly upon
swollen A. fumigatus spores, which have more PAMPs exposed35. They are responsible for
phagocytosing spores and preventing germination. Macrophages and monocytes also enhance
recruitment through production of TNF-α and Granulocyte-Macrophage Colony-Stimulating
Factor (GM-CSF). Signaling through PRRs leads to production of IL-1 family cytokines through
the NF-𝜅B pathway, leading to inflammatory responses and the 1st wave of recruited immune
cells, the neutrophils (Figure 7). The importance of neutrophils is heavily underscored in that
neutropenic patients are among those with highest risk of contracting invasive aspergillosis.
Neutrophils have numerous anti-fungal immunity functions observed against A. fumigatus
including NETosis, reactive oxygen species production (ROS) and phagocytosis36. For
immunocompetent individuals, the anti-fungal activity of macrophages and neutrophils at this
stage of the innate response is sufficient for clearance of inhaled spores. This initial barrier of
host defense is largely responsible for management of infection however an important additional
wave of recruited immune defense cannot be overlooked.
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The 2nd wave of recruited cells includes dendritic cells, which can transport and present spore
PAMPS to naïve T cells in nearby lymphoid tissue and thus may lead to acquired immunity.
Dendritic cells are also responsible for secreting chemokines for additional innate recruitment,
including additional neutrophil recruitment. The exact roles and importance of members of the
2nd wave (Figure 7) of recruited cells, such as NK cells is an area of active research. Innate
lymphoid cells are more recently implicated in anti-fungal immunity. Their response includes
production of cytokines IL-17A, and IL-22 although their mechanisms of action in invasive
aspergillosis are still under exploration37.

Figure 7 Immediate, early, and later waves of the innate immune response against A.
fumigatus infection upon inhalation Published in Espinosa et al 201638
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1.3.2. Highlighting the neutrophil and macrophage response to A. fumigatus
Neutrophils have been long recognized as a crucial component of the innate immune response to
A. fumigatus, studies have noted that depletion of neutrophils but interestingly not macrophages,
significantly reduces survival of infection39. Neutrophils are the primary effector cell in
destroying A. fumigatus hyphal growth and have been demonstrated to be essential for survival
in both zebrafish and murine models39,40, consistent with the high susceptibility seen in
neutropenic patients. Although neutrophils can phagocytose fungal spores, evidence suggest the
primary anti-fungal activity of neutrophils in invasive aspergillosis lies in any of 3 modes of
action: Expelling of antimicrobial hydrolytic enzymes upon degranulation, NADPH mediated
ROS production, and NETosis have all been explored as possible sources of neutrophil-mediated
killing of A. fumigatus37(Figure 8). It is worth mentioning that neutrophil depletion in animal
models has been a consistent method for studying invasive aspergillosis due to their inability to
eliminate hyphal growth, consistent with neutropenic patients, and highlighting the importance
of this cell type.

Figure 8 Innate immune antifungal responses observed in neutrophils
during infection with A. fumigatus Published in Garth et al 2017 37
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Alveolar macrophages perform roles associated with reduction of A. fumigatus spore burden, and
as residents of the possible infection site, also serve a preventative measure against disease.
Macrophages are the primary phagocytes in this infection and recognize fungal β-glucan through
the CLR Dectin-1, leading to phagocytosis of spores and induction of inflammatory responses41.
Phosphatidylinositol 3-kinase (PI3K) and actin polymerization are initial steps required for
phagocytosis of A. fumigatus42 with the phagocytic cup forming within the first minutes of
macrophage contact with a spore (Figure 9). The intracellular fate of conidia is then determined
by steps tied to phagosome maturation. Upon maturation of conidia containing phagosomes into
phagolysosomes acidification is a key step in macrophage-mediated killing of A. fumigatus
spores42. This compartment acidifies and has been shown to contain lysosomal hydrolases
including cathepsin D. The importance of acidification in these compartments for killing of A.
fumigatus has been shown by inhibiting the vacuolar proton ATPase pumps necessary in
acidification, resulting in greatly reduced spore killing in vitro42. As producers of the immunemodulatory cytokine GM-CSF, macrophages also enhance neutrophil recruitment and
conidiacidal activity44.
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Figure 9 General macrophage response and mechanisms for spore killing (spore shown as
green circle with red border).

1.4 Rac2 and Innate Immune System Function
1.4.1. Regulation of innate immunity by rho-GTPase Rac2
Rho GTPases are a super-family of proteins comprised of Cdc42, Rho, and Rac subfamilies.
Proteins in these families are generally known for regulatory roles, and operate in a molecularswitch fashion, with a GTP bound active form, and a GDP bound inactive form. Currently, there
are three known isoforms of Rac known: Rac1, Rac2, and Rac3. These isoforms differ in where
they are expressed, where rac1 expression is ubiquitous, and rac2 expression is specific to
hematopoietic cells, including macrophages and neutrophils45. The expression of rac3 is also
restricted to certain tissues including neurons, however its exact area of expression is uncertain
46

. Rac2 is heavily implicated in various leukocyte functions, both in humans and in zebrafish.

Regulatory roles characterized for Rac2 include but are not limited to chemotaxis, phagocytosis,
and respiratory burst45,47(Fig. 10). Innate phagocytes are necessary in controlling A. fumigatus
22

infection, showing 100% mortality when neutrophils and macrophages are absent from
zebrafish48.

1.4.2. Rac2 and primary human immunodeficiencies
Mutations to the rac2 gene in humans, though exceedingly rare, have provided direct insight into
the consequences of improper/lack of function. Among the rac2 mutations studied in humans,
the mutation in codon 57 substituting asparagine for aspartate (D57N) has been studied
extensively. This mutation was found to result in failure of Rac2 to bind GTP and thus results in

Figure 10 General mechanism behind activation of Rac2. Active (GTP bound) and inactive
(GDP bound) forms and associated regulatory processes are shown. (Created with BioRender)
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a loss of function. Widespread defects in neutrophil functions were observed including defects in
neutrophil chemotaxis, phagocytosis, degranulation, superoxide anion production, and general
bactericidal activity49-51 highlighting the importance of Rac2 in proper innate immune function.
Hypogammaglobulinemia, a condition characterized by failure to produce sufficient
immunoglobins, has also been characterized in a patient with the D57N rac2 mutation caused by
B-cell lymphopenia, indicating Rac2 serves important regulatory roles involved in the adaptive
immune response as well52.

1.4.3. Rac2 and impaired innate immune responses in vitro vs. in vivo
In vitro studies have been demonstrated that rac2-/- mice peritoneal exudate neutrophils have a
significant impairment in primary granule release in response to chemoattractant stimulation.
Inhibition of the granule translocation process was found to be inhibited 53. Secondary and
tertiary granule burst was not found to be affected in rac2-/- neutrophils. Superoxide generation
through the NADPH oxidase complex was demonstrated to require Rac2 active. Motility defects
in neutrophils have also been recapitulated in studies relying on primary murine neutrophils 54.
This is largely consistent with in vivo impairments in the rac2 -/- neutrophil, with reduced
neutrophil motility and ROS production53,55,56. Murine neutrophil, mouse, and zebrafish models
demonstrate a consistent great impairment in neutrophil motility and chemotaxis in response to
infection, wounding or chemoattractant stimulation indicating Rac2 is primarily responsible for
orchestrating neutrophil mobilization. In vitro methods have revealed Rac2-deficient murine
macrophages have defects in phagocytosis and reactive oxygen species (ROS), which present
based on the method of stimulation57. In mice Rac2 was demonstrated to have regulatory roles
in macrophage alternative activation, with impaired M2 activation and predominantly the
24

inflammatory M1 phenotype persisting. This suggests Rac2 controls expression of genes
involved in M2 macrophage differentiation58.
In vivo studies consistently find immuno-impairments in leukocyte responses to infection in
rac2 -/- mutants, consistent with observations of the D57N loss of function mutation studied in
humans. Consequences of the loss of function D57N rac2 mutation in neutrophils include near
complete loss of motility and high mortality in zebrafish compared to control, with overlapping
defects also found in rac2-/- mice40,48,54,55.

1.5 Zebrafish as a Model for Studying Infectious Disease and Immune Response
1.5.1. Zebrafish, infections, and innate immune response
Zebrafish have been used as a model organism for approximately 30 years, with initial use
concentrated in developmental biology. Zebrafish possess all hallmarks of a successful and
reliant model organism, with high fecundity, rapid development (Fig. 11), a fully sequenced
genome, dedicated database (ZFIN), and genetic tractability60,61. The zebrafish model has gained
prominence in the study of host-pathogen interactions demonstrating its versatility and
adaptability for study in various fields. This model is particularly well suited for study of the
innate immune system due to its early development of just ~36 hours, along with a functional
circulatory system. Due to the absence of a developed adaptive immune system, which takes ~3
weeks before becoming active, this allows for study of innate immune response in isolation of
adaptive immune components. Perhaps the most distinguishing feature of this model organism is
the transparency of the skin at early larval stages; This allows for in vivo visualization of hostpathogen interactions and infection dynamics, and access to a unique perspective to uncover
mechanisms that may not have been possible in vitro or in other models.
25

Figure 11 Developmental lifecycle of the zebrafish59 (Created with Biorender)

1.5.2. In vivo techniques and molecular tools for studying host-pathogen interactions
Due to the unique advantage the zebrafish model confers with its early larval transparency,
confocal fluorescence microscopy techniques have been and are currently used extensively to
characterize host innate immune interactions with bacterial, viral, and fungal pathogens61.
Pairing in vivo microscopy imaging with distinguishable fluorophore expressing/labeled
macrophages, neutrophils, and/or pathogens has enabled the detection of events such as shuttling
of fungal conidia from neutrophil to macrophage61, an event difficult to capture in vivo in a
different model organism. Timelapse video and multiple timepoint imaging in the same zebrafish
allow for precise capture of leukocyte recruitment, changes in pathogenesis, and altering of cell
phenotypes such as macrophage polarization or membrane ruffling. Additionally, defects caused
26

by the D57N rac2 mutation result in similar immunodeficiencies as observed in humans
including defects in neutrophil responses. The zebrafish innate immune response to A. fumigatus
is similar to that in humans at the cellular level, with initial response by macrophages, followed
by neutrophils40,48,62.
1.6 Rationale
The prevalence of immunotherapy in treating infections is currently minimal, as it is a
relatively novel application, even more so regarding fungal infection. An effective and rapid
innate immune response is crucial role in clearing fungal infection, as hyphal growth or
dissemination must be prevented to avoid mortality or severe morbidity. Early responders to
A. fumigatus infection include macrophages and neutrophils. Studies highlight that depletion
of neutrophils has a detrimental effect on survival for zebrafish larvae during A. fumigatus
infection, where this detriment is also present to a reduced degree when macrophages are
ablated40,48. Despite the difference in survival outcome, opportunities for enhancing
neutrophil response to this infection have yet to be revealed. Importantly, interactions
between neutrophils and macrophages during A. fumigatus infection have been
characterized40,42,48,62. Among these interactions the shuttling of conidia from neutrophils to
macrophages, as well as lateral transfer between macrophages has been observed, bearing
important implications in the progression of pathogenesis. These interactions pose multiple
possible instances to intervene with A. fumigatus pathogenesis, including in the earlier stages,
where macrophages have been shown to predominate40,48,62. The observed abilities of
macrophages to cluster around A. fumigatus conidia and phagocytose/kill them suggests this
cell type is instrumental in reducing initial fungal burden early on in infection, as
phagocytosis and inhibition of germination are its main roles. Interestingly, A. fumigatus has
27

been repeatedly observed to germinate and grow within macrophages in vivo. The
opportunity to enhance macrophage function, and potentially eradicate this intracellular
niche, exists in a protein called Rac2. Based on previous studies and literature, Rac2 seems to
function in a pathogen-dependent and leukocyte-dependent manner. It is for this reason that it
is necessary to study the roles of Rac2 during A. fumigatus infection specifically, in order to
better understand its influence on macrophage functions implicated in A. fumigatus killing.
The observation that neutrophils lacking in Rac2 have nearly complete loss of motility
renders them incapable of reaching an infection site. Thus, macrophage migration,
phagocytosis, phagolysosome function, and ability to inhibit germination are of primary
interest to investigate. In A. fumigatus infection, macrophages are the first-line defense, thus
it makes sense to investigate the roles of Rac2 in an immediately impactful cell type. The
zebrafish model provides the ability to observe all these processes in vivo.
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2. Materials and Methods
Zebrafish Lines
Zebrafish maintenance and handling was done according to protocols approved by the
Clemson University Institutional Animal Care and Use Committee (AUP2018-070, AUP2019012, and AUP2019-032). Zebrafish adults were maintained at 28⁰ C at 14/10 hr light/dark cycles.
All mutant and transgenic fish lines used in this study are listed with reference provided where
applicable (Table 1). Zebrafish adults were crossed to obtain offspring. Embryos were collected
and maintained in E3 medium with methylene blue at 28⁰ C or transferred to a 200 μM Nphenylthiourea (PTU) containing dish within 24 hours of fertilization to inhibit pigment
formation.
Table 1 Zebrafish lines used
Line Name
AB (Wild-type/non-transgenic)
rac2+/mfap4:tdTomato
mpeg1:mCherry-2A-rac2WT
mfap4:BFP
Tol2-mfap4-YFP-GS-rac2

Origin
(48)
(40)
(48)
E. Rosowski, unpublished
This study

rac2 Genotyping In Zebrafish Adults and Larvae
rac2 genotyping of adults was performed on genomic DNA extracted from a clipping of caudal
fin tissue whereas rac2 genotyping of larvae was performed on genomic DNA extractions from
whole larvae. Genomic DNA extraction was achieved through tissue degradation, using heat and
50mM NaOH. PCR of genomic DNA for the rac2 gene was done using rac2 primers as follows:
rac2_ex5_F:CACTGCCCTTCCACTCCAAT
rac2_ex5_intronR:GACAAATCCAGCTCTGCCAC.
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PCR was performed using GoTaq Green 2x master mix (Promega). Restriction digest with
HindIII done after PCR cleaves rac2 DNA into 39bp and 125 bp fragments and cannot cleave
rac2 mutant DNA as the HindIII restriction site is lost due to the D57N nonsense mutation
present, thus only a single band of 164bp is present. Zebrafish heterozygous for rac2 present
bands of all these lengths, and it is on this basis that the rac2 genotype of zebrafish adults and
larvae was determined for this study. The rac2 heterozygous adults were already established in
the lab (Table 1).
Aspergillus fumigatus Strain Af293 Growth and Preparation
In this study, the TBK1.1 derivative of the Af293 strain of A. fumigatus was used. TBK1.1
possesses GFP fluorescence. Growth of this strain was done on glucose minimal media (GMM)
as previously described63. Stock solutions of spores were of 1.5 X 108 spores/mL concentration.
Af293 Live-dead Spore Preparation/Labeling
TBK1.1 spores were biotinylated and conjugated to streptavidin-AF633 in order to link a far-red
fluorophore to all A. fumigatus spores and achieve constitutive fluorescence in contrast to the
promoter mediated GFP fluorescence of TBK1.1. Labeling of TBK1.1 spores with AF633 was
done as previously described64.

Lysotracker Staining of Lysosomes
Fluorescent staining of lysosomes was achieved through addition of Lysotracker Red DND-99
(Invitrogen) directly into E3 containing 2 dpf zebrafish larvae for 45 minutes and rinsing again
with E3 before immediate viewing, as previously described65.
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Zebrafish Infection and Spore Microinjection
The hindbrain region was used as the infection site for all experiments involving infection. This
region is a cavity at the time of injection. From stock solution, spores were diluted in PBS for
injection with phenol red dye for tracking purposes. Larvae were anaesthetized using tricaine in
E3 water, and injected on an agarose petri dish, preheated to 37⁰ C, and coated in bovine serum
albumin (BSA) to minimize risk of abrasions occurring. Injections were done using pulled glass
needles and with the assistance of a microinjection system for guidance of needles.

Figure 12 Zebrafish hindbrain injection scheme A microinjection needle is shown injecting
spores and phenol red into the hindbrain cavity of a zebrafish larvae (Made with Biorender)
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Morpholino Preparation and Microinjection
The rac2 translation blocking morpholino “5' - CCACCACACACTTTATTGCTTGCAT – 3”
was used as a means to inhibit rac2 mRNA translation (Gene Tools). This morpholino has
previously been demonstrated effective at inhibiting translation of rac2 mRNA in previous
publications66-70. For control, a control morpholino with no mRNA binding activity was used.
Morpholinos at working concentrations of 100 µM were injected into embryos at the 1-cell stage,
using a grooved agarose plate to secure embryos for injection, which was done with pulled glass
needles and assistance of a microinjector. Morpholino mixes were composed of 1 µl morpholino
to be injected, 1 µl phenol red dye for tracking, 0.5 µl 0.5X CutSmart Buffer (NEB) and brought
to 10 µl total volume with water. Importantly, all microinjections done with
morpholinos/embryos used a separate injection station than those used for infections to reduce
contamination risks.

Survival Assays
Survival assays were completed to assess outcome of A. fumigatus infection in rac2 wild-type vs.
rac2 -/- mutants and examine the broad physiological consequences of absence of rac2 in both
neutrophils and macrophages. Microinjection of fungal spores into the hindbrain of ~48
zebrafish larvae was performed for each experimental replicate. Additionally, 8 larvae were
randomly selected, euthanized, and homogenized for plating on GMM. This was done in order to
approximate the fungal burden each larvae received, through enumeration and averaging of
CFUs in each set of 8 larvae per experimental group. Larvae were then kept in a labeled 96 well
plate, held at 37⁰ C. Status of each larvae was monitored daily for a 7-day infection period, and
times of deaths were noted. Upon completion of tracking survival, PCR for rac2 was done for
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every larvae, and rac2 mutants were determined allowing for comparison between experimental
groups.

Macrophage rac2 rescue survival assays were also conducted. This was done using the rac2
morpholino to block translation of wild-type genomic rac2 in larvae as before, however the
mpeg1:mCherry-2A-rac2WT “macrophage rescue line” was used in this experiment, which
contains a distinct copy of rac2 expressed under the macrophage specific promoter mpeg1. As
the rac2 morpholino used does not recognize this macrophage specific transgenic copy of rac2,
its translation remains uninhibited thus allowing for only the macrophage cell type to regain rac2
expression hence the term “rescue”. A control morpholino injected control group was included
for the wild-type zebrafish group and for the mpeg1:mCherry-2A-rac2WT zebrafish group in
each rescue survival experiment conducted. Macrophage rac2 rescue survival assay experiments
are currently at an insufficient number of replicates for statistical analysis to be conducted, thus
the methodology and data involved in these particular experiments can be found in
supplementary materials (Fig. S2).
In vivo Imaging
Zebrafish embryos destined for live imaging were moved from E3 into E3 treated with the
chemical PTU, which inhibits melanogenesis, thus blocking pigmentation to ensure full
transparence of the larvae is maintained throughout the duration of imaging days. Importantly,
zebrafish were treated with PTU immediately or no later than within 24 hours of birth to prevent
any prior to treatment pigmentation from developing. At 2 dpf, larvae were phenotyped for
presence of their respective fluorescent protein(s) under microscope. Larvae with fluorescent
macrophages were then selected for hindbrain infection. On the day of imaging, larvae were
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anaesthetized with tricaine and aligned in specialized petri dishes (Fig. 13) to ensure the imaging
site (hindbrain) remains as static as possible. Larvae were imaged using a Zeiss Cell Observer
Spinning Disk confocal microscope on a Axio Observe 7 microscope stand with a confocal
scanhead (Yokogawa CSU-X) and a Photometrics Evolve 512 EMCCD camera. A PlanApochromat 20x objective (0.8 NA) and ZEN software were used to acquire Z-stack images of
the hindbrain area with 5 μm distance between slices. After imaging, larvae were rinsed with 200
μM PTU in E3 and put back in the same well. Fluorescent channel selection, Z-stack
configuration, and image acquisition was done in Zen 3.3 (Zeiss) software.

Figure 13 Plate specialized for imaging zebrafish. Zebrafish are held in place and aligned for
clear viewing of the hindbrain region. (Made using Biorender)
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Imaging Analyses
Image analysis for macrophage migration, phagocytosis, and germination was done within ZEN
3.3 using the full Z-stack output and axis to determine applicable data. Fluorescence signals
associated with macrophages were quantified within a defined hindbrain region. Phagocytosis of
spores was determined by confirming internalization of GFP spore signal within magenta
macrophage signal using Z axis views which are reflective of the 3d distribution of fluorescence
signal. Fluorescence intensity was also modified at times for clearer contrast/distinguishing
between macrophages. For live-dead spore analysis, Fiji was used to split channels into separate
fluorophores, and the cell counter feature was used to enumerate GFP (live-spore) and AF633
(constitutively active) fluorescent signals. Through comparison of these, killed spores were
determined.

Sudan Black Neutrophil Staining
Due to near complete absence of motility in neutrophils lacking Rac2, Sudan black staining of
neutrophils was performed for 12 larvae per condition wherever morpholino use was concerned.
This was done as a control to check the success of morpholino injections. Caudal fin transection
was done to provide migratory stimulus and following 2 hours, neutrophils were stained as
previously described40,48.
CFU Assay
The CFU assay technique was primarily used to assess the reduction in fungal burden between
rac2 vs. control morpholino treated zebrafish larvae however, it was also used to approximate
the initial fungal burden for survival assays. For assessment of fungal burden reduction, ~60-80
embryos were injected with control morpholino and the same amount, with rac2 morpholino.
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Following hindbrain infection, 8 larvae per treatment were selected and euthanized. Individual
larvae were moved to 1.5 mL Eppendorf tubes, and each filled with 90 µl of PBS containing 1%
ampicillin and 1% kanamycin to select for only A. fumigatus. Larvae were homogenized and
spread onto GMM as previously described40. Plates were incubated for 2 days at 37⁰ C followed
by 2 days at room temperature before enumeration of A. fumigatus colonies. This process was
repeated daily for days 0-4. All data was normalized to initial fungal burden at day 0.
Plasmid Construction and Establishment of Transgenic Zebrafish
Construction of the Tol2-mfap4:YFP-GS-rac2 plasmid (Fig. 14) was achieved by cutting a Tol2mfap4 vector with restriction enzyme SalI. This vector includes Tol2 transposase sequence arms
and the mfap4 macrophage specific promoter. Next, the YFP gene was amplified through PCR
from pDestaatB-CY pCM327 (AddGene) with the following primers:
F: GACTTTAGATCGTGGTCGACCTGACAACATGGTGAGCA
R: TCCGCTTCCGCTTCCCTTGTACAGCTCGTCCAT
The rac2 gene was amplified through PCR from the already made plasmid Tol2-mpx-mCherry2A-rac2 with the following primers:
F: GGAAGCGGAAGCGGAATGCAAGCAATAAAGTGT
R: ATAGTTCTAGATCAGTCGACTTAGAGCATCACGCAGCC
Within this primer sequence is the gap sequence (GS) “GGAAGCGGA AGCGGA”. All
fragments were annealed with HiFi DNA Assembly kit (NEB). Plasmid was amplified within
highly competent NEB 5-alpha Escherichia coli on Luria broth ampicillin plates to select for
transformants. Isolation of plasmid and sequencing confirmed successful plasmid assembly.
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In order to establish a transgenic line of zebrafish expressing YFP fluorescent Rac2, 1 µl
containing ~400ng of plasmid was added to a mix containing 1µl of phenol red dye, 0.5 µl
CutSmart Buffer (NEB), 1 µl containing 100ng of transposase mRNA, and 6.5 µl of water. This
mix was injected into the yolk of zebrafish embryos at the 1 cell stage. Zebrafish were screened
for YFP fluorescence with a fluorescent microscope and grown to adulthood. Offspring of these
adults were screened to confirm germline integration of YFP-Rac2 fluorescence and placed on
the fish system to form the F1 generation of this transgenic line.
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Figure 14 Complete structure of Tol2-mfap4:YFP-GS-rac2 plasmid, with all fragment site
labels in their respective fragment color. (Figure generated with A plasmid Editor (ApE))
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Statistical Analyses
All statistical analyses were performed on a minimum of 3 experimental replicates. For survival
assays, Cox proportional hazard analysis was performed using the survival package in R. This
analysis yields P values between conditions as well as hazard ratios (HR). This analysis was also
performed on germination events in imaging experiments. Additionally, Fisher’s exact tests were
performed in R for all individual time points indicating high differences in occurrences of
germination between experimental groups. Data involving counts such as macrophage migration
and percent phagocytosis was analyzed with estimated marginal means (emmeans) in R, which
also generates standard error outputs. All statistical analyses were performed in R, and graphs
were either outputs from R colorized with photoshop or made in Excel/Google sheets.
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3. Results
Absence of Rac2 in neutrophils and macrophages imparts an immuno-impaired response
to A. fumigatus in vivo
I began by assessing the survivability of zebrafish lacking Rac2 in neutrophils and macrophages
to recapitulate a striking impairment in innate immune response to A. fumigatus. This
impairment confirms the general importance of Rac2 in the immune response to this infection. I
used the slower germinating Af293 strain of A. fumigatus in this study to allow for greater time
to observe early stages of pathogenesis, particularly in later imaging experiments. The immune
response of rac2 mutant zebrafish larvae (rac2-/-) is clearly impaired, as indicated by a
significant decrease in survival upon challenge with A. fumigatus conidia (Fig. 15B). This is
despite the use of the slower germinating Af293 strain (compared to the CEA10 strain).
Importantly, absence of rac2 expression in neutrophils has been previously demonstrated to
cause significant increases in death40,48. Because rac2-/- macrophages retain basic motility and
have major roles in early responses to A. fumigatus infection. I focused on the importance of
Rac2 function in macrophages and its contributions to host survival of infection moving forward.
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Figure 15 Rac2 mutant zebrafish larvae have a significantly impaired immune response to
A. fumigatus. A. The hindbrain injection site used for all infections is shown, with phenol red
indicator co-injected to confirm successful injection. B. Zebrafish larvae challenged with ~72
CFUs of A. fumigatus were tracked for survival of infection over a 7-day period. Control group
n=113 included zebrafish larvae with at least 1 copy of functional rac2, Rac2-/- group n =32
included larvae with no functional rac2 gene. Survival analysis was performed in R, yielding
p= 3.18−11 and a hazard ratio (HR) of 8.8. C. Examples of the appearance for each possible
rac2 genotype are shown on a gel displaying (from left to right) rac2 heterozygous, wild-type,
and Rac2 mutant band patterns.
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Rac2 is not necessary for macrophage migration or phagocytosis of A. fumigatus spores
Using the rac2 heterozygous fluorescent macrophage labeled zebrafish line mfap4:tdTomato, I
crossed adults of this line to obtain offspring with cytosolic macrophage fluorescence and
varying rac2 copies. Typical distribution of genotypes for embryos included ~50% rac2+/-,
~25% rac2+/+, and ~25% rac2-/-. After screening larvae for cytosolic macrophage fluorescence,
I infected larvae with the Af293 derived GFP expressing TBK1.1 strain of A. fumigatus,
allowing macrophage migration and phagocytosis of spores to be visualized. Initially, I had
completed only 3 experimental replicates, noticing no significant differences in macrophage
migration or spore phagocytosis observed during any particular day of infection. I observed that
some larvae among these replicates had few spores present in the hindbrain and therefore
performed an additional 3 experimental replicates. This time I included only larvae which had a
minimum of 20 spores present in the hindbrain region of infection in these new imaging
replicates. Interestingly, the fungal burden did not reveal any differences in macrophage
migration or phagocytosis behavior either. I have therefore chosen to merge all 6 experimental
replicates. Unsurprisingly, analysis did not reveal significant differences between rac2 or rac2-/larvae (Fig. 16B, 16D).
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Figure 16 Macrophage migration and phagocytosis responses to A. fumigatus are
unaffected by absence of functional Rac2. A. Cytosolic fluorescence of a macrophage is
indicated (magenta color) by the white arrow. B. Analysis of 6 experimental replicates was done
using emmeans in R to compare the number of macrophages migrating to the hindbrain infection
site over a 5-day infection period. Emmeans analysis yielded no significant differences at any
time point. Groups compared were Rac2 expressing Control n = 52, and rac2-/- zebrafish larvae
n = 19. C. Cytosolic fluorescence is shown (magenta) along with GFP expressing spores
(Green/Teal). Z axis, X, and Y views are also shown. An example of phagocytosed spores is
indicated by the white arrows. D. Analysis of 6 experimental replicates was done using emmeans
in R to compare the percentage of spores being phagocytosed between control n = 52 and rac2-/n =19 zebrafish larvae, over a 5-day infection period. Emmeans analysis yielded no significant
difference between these groups at any given time point.
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Macrophage Rac2 is not required to decrease fungal CFU burden
I next focused on the implications of Rac2 involvement in macrophage-mediated spore killing.
By homogenizing whole larvae and plating, I was able to enumerate CFUs on the day of
infection to establish the average initial fungal burden for each experimental group.
Experimental groups for this analysis consisted of wild-type zebrafish treated with either a
control morpholino or a rac2 morpholino. To verify the efficacy of rac2 morpholino use, I relied
on Sudan black staining of neutrophils to verify neutrophil immobility, a previously
characterized phenotype of rac2-/- neutrophils (Fig. S1). I repeated CFU burden experiments for
a total of 4 experimental replicates, yielding no statistically significant difference in the fungal
burden reduction capability of rac2 morpholino treated larvae. Control and rac2 morpholino
experimental groups show maximum difference in fungal burden reduction at 2 days postinfection (Fig. 17B). I am currently further exploring deficiencies in spore killing for
macrophages in Rac2 mutant zebrafish.
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Figure 17 A. fumigatus CFU burden clearance is not significantly impaired in Rac2-/zebrafish larvae. A. Experimental design for homogenizing infected larvae, spreading on a
plate, and enumerating fungal CFU counts after incubation is shown. B. Differences in clearance
of initial fungal burden between the Rac2 expressing Control group n= 153 and Rac2-/- group n=
157 larvae were compared using emmeans analysis in R on the 4 experimental replicates
completed. The greatest difference between groups for % CFUs of fungal clearance was at 2
days post-infection, p = 0.15.

Macrophage Rac2 promotes suppression of A. fumigatus germination
Suppression of germination is a major function of macrophages in the A. fumigatus infection.
Accordingly, I shifted focus on the ability of macrophages in Rac2 mutant larvae to suppress
germination. Deficiencies in this process would bear further implications in defective spore
killing. Through scoring individual zebrafish larvae for presence or absence of fungal
germination, I was able to compare the ability of macrophages to suppress germination in control
and Rac2 mutant larvae. After scoring all zebrafish in a total of 6 replicates of imaging
experiments I found that Rac2 mutant zebrafish had significantly greater occurrences of
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germination despite uninhibited macrophage migration and phagocytosis (Fig. 18B). I had also
noted a behavior of macrophages for both experimental groups involving macrophage clustering
around spores, which in many cases, seemed to provide a protective niche to allow fungal
germination. Due to this observation, I then looked at germination within macrophage clusters
and compared between groups to assess whether lack of Rac2 in macrophages exacerbated this
protective niche. Though a higher percentage of rac2-/- larvae exhibited intracluster germination,
the difference between groups was not significant (Fig. 19B).

Figure 18 rac2-/- macrophages are impaired in their role to suppress fungal germination.
A. Example of A. fumigatus germination shown, indicated by presence of branch-like hyphae
(Green). Germination is shown breaking through from within a macrophage (Magenta) B.
Occurrences of germination were measured and compared across 6 replicates between Rac2
expressing control n= 52 and rac2-/- n= 19 zebrafish larvae. The asterisk in the upper left refers
to p= 0.02983 from the survival analysis conducted in R. A hazard ratio of 2.09 is also reported.
The asterisk on the right comparing groups at day 5 refers to p= 0.02749 from Fishers Exact
Test, also done in R.
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Figure 19 The observed macrophage intracluster fungal-protective niche is not exacerbated
by absence of Rac2 in macrophages. A. An example of intracluster germination is shown, with
macrophages (Magenta) completely surrounding A. fumigatus spores (Green) and presence of
germination. B. Mosaic plot generated from Fishers Exact Test conducted in R, p= 0.2882,
indicates that though a higher percentage of rac2-/- zebrafish larvae experience Intracluster
germination in macrophages than seen in control larvae, this difference is not significant.
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4. Discussion
I have used the zebrafish model to elucidate the importance of Rac2 in multiple roles of the
macrophage during Aspergillus fumigatus infection; Using imaging techniques to lean on the
strengths of this transparent model organism to visualize host-pathogen interactions and
characterize rac2-/- macrophage behavior. The Z stack imaging approach has allowed for
visualization of the in vivo infection dynamics of macrophages and A. fumigatus in a 3d space,
and importantly, tracking of pathogenesis in the same zebrafish across multiple timepoints. The
general importance of Rac2 expression during A. fumigatus infection was previously
demonstrated in zebrafish48 . I first recapitulated this observation to confirm presence of this
immunocompromised phenotype, which was indeed present (Fig. 15B). With the general
physiological importance of Rac2 implicated in survival of A. fumigatus infection, the
macrophage specific roles of Rac2 were of interest for this project. Notably, previously also
demonstrated in the same study48, near complete absence of motility in rac2-/- neutrophils but
not macrophages, indicating that processes involved in infection responses for Rac2 in
neutrophils at the infection site cannot be studied in vivo via the loss of function angle.
Macrophages were therefore of focus for this study.

Due to the many associations between Rac2 and roles in leukocyte motility and migration shown
both in studies and in ontology searches, roles of Rac2 in macrophage migration and
phagocytosis in the A. fumigatus infection site were examined first. Macrophages
chronologically are the first to respond to this infection as they are resident cells at the infection
site used. Neutrophils are the first recruited responders to arrive, thus the innate immune

48

responses in humans and zebrafish are similar at the cellular level. Intriguingly, there were no
apparent differences in the ability of rac2-/- macrophages to migrate to or phagocytose spores
when compared to Rac2 expressing macrophages (Fig. 16 B, D). This indicated that although
roles for Rac2 in migration and phagocytosis exist, they may be either redundant or mainly
associated with different signaling pathways/molecules such as Rac1. With no apparent defects
in the abilities for rac2-/- macrophages to migrate to A. fumigatus infection sites or phagocytose
spores, I proceeded to focus on differences in the ability of the macrophage to suppress
germination of spores once phagocytosed.

From the initial 3 replicates of imaging experiments performed, average fungal burden in
zebrafish for both the control and rac2-/- groups had considerable variance and relatively low
burden. Despite this I found significantly more occurrences of germination in rac2-/- larvae (Fig.
S3 B). To assess possible influences amount of fungal burden could have on germination I
completed 3 additional experiments (replicates 4-6), this time with an initial burden minimum of
20 spores in the hindbrain region of imaging. While the rac2-/- group maintained the higher
number of germination occurrences, this gap was somewhat bridged by the control group (Fig.
S3 C). This observation indicated that higher fungal burdens result in more frequent germination
regardless of Rac2 status. A key observation was that rac2-/- macrophages fail to suppress
germination despite presence of few spores when compared to control larvae. Upon analysis of
total occurrences of germination per group regardless of spore burden, significantly more
occurrences in germination are still present in the rac2-/- mutants (Fig. 18B). Notably,
germination in rac2-/- larvae occurs rapidly, often resulting in death within 24-48 hours.
Resolution of germination was rare in the rac2-/- larvae group, likely due to the inability of
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rac2-/- neutrophils to arrive to the infection site to destroy hyphae. In instances of germination
in control group larvae, resolution of germination was quite common, especially at lower fungal
burdens.

I frequently observed clustering of macrophages around fungal spores in both experimental
groups. Clustering typically occurred only after a minimum of 2 days of infection. Due to
relatively frequent observations of intracluster germination of A. fumigatus spores in groups of
macrophages (Fig. 19A). I proceeded to score individual zebrafish for these occurrences to see if
they skewed heavily towards a single experimental group. Macrophage clusters seemed to
provide a protective niche for fungal germination in instances where spores were not promptly
killed. Likely, the steric blocking effect of macrophages directly prevented neutrophils from
interacting with early germination and hyphal growth. After analysis, I did not find intracluster
germination in macrophages to be uncommon for either experimental group (Fig. 19B) thus, it
does not seem fungal protective effects of macrophage clustering are exacerbated by absence of
Rac2 in involved macrophages.

Though Rac2 promotes suppression of A. fumigatus germination, questions remain about
implications for Rac2 in spore killing, particularly as this is a large part of how macrophages
manage early fungal burdens to help prevent invasive aspergillosis. I first broadly assessed for
spore killing defects with a CFU enumeration technique (Fig. 17A). Comparison of control and
Rac2-/- larvae abilities to reduce initial fungal burden deviated noticeably but not significantly
(Fig. 18B). Fungal burden reduction occurred slower in the Rac2-/- deficient group, with the
greatest differences in burdens peaking at 2 days post-infection. Because fungal burdens seemed
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to convene by 4 days of infection, and standard error values were relatively high, these groups do
not significantly differ in fungal burden even for day 2, p= 0.15. Variance in fungal CFU counts
between plates likely contributed to standard error returned by emmeans analysis. Importantly,
hyphae do not produce multiple CFUs but rather only a single CFU when grown on GMM media
thus, this technique cannot account for germination not accurately reflect fungal burden in terms
of actual fungal biomass present. For this reason, spore-killing is currently being directly
measured.

Current Experiments
Currently, I am directly measuring spore killing between control and Rac2-/- groups of larvae
using live-dead reporter A. fumigatus spores (Fig. S4). Spore killing is being measured
specifically at 48 hours post-infection. Additionally, I’m focusing on investigating macrophage
lysosome acidification with lysotracker staining, as measuring spore killing specifically in
acidified compartments can reveal possible impairments in phagolysosome-mediated killing
caused by lack of Rac2. .

Conclusions and Future Steps
Rac2 is needed for proper innate immune response to A. fumigatus. Though Rac2 does not seem
required for macrophage migration to the infection site nor for phagocytosis of spores, it does
promote inhibition of fungal germination after phagocytosis has occurred. This role in
suppression of germination is most clear at lower fungal burdens but is still apparent at higher
burdens as well (Fig. S3 B, C ). Conclusions on possible roles for macrophage Rac2 and spore
killing cannot yet be made at this time.
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Immediately of interest is to conclude current experiments investigating spore killing in Rac2-/macrophage lysosomes and general infection sites. These experiments will allow for analysis of
spore killing with a direct method, in contrast to the CFU enumeration technique used thus far.
These experiments will also give information on lysosome/phagolysosome acidification and may
thus elucidate potential roles for Rac2 in these processes. Beyond lysotracker and live-dead
imaging, future work will involve use of the Tol2-mfap4:YFP-GS-rac2 (Fig. 14) zebrafish line
to visualize which membranes Rac2 localizes to during A. fumigatus infection. Other possible
avenues for future work lie in examining possible roles for Rac2 in macrophage-mediated ROS
production as a means for spore-killing in this infection. To assess the broader physiological
impacts of macrophage Rac2, effects of rac2 expression in macrophages but not neutrophils
should be assessed and compared to positive and negative controls (Fig. S2). Though 2 replicates
of this experiment has been done, this should be completed from scratch using a new generation
of mpeg1:mCherry-2A-rac2WT (“rescue line”) zebrafish. This will allow for insight on possible
therapeutic effects of the macrophage Rac2 target including comparison of infection survival and
possible associations with delays in mortality, which may be caused by suppressive effects
shown on germination.
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Figure S1 Results from Sudan black staining of neutrophils to verify rac2 morpholino
efficacy. A-E. Data showing average neutrophil count migrating to a tail wound stimulus is on
the left, with data for individual zebrafish larvae shown on the right. The data for A-E is shown
chronological to the order the experiments were performed as follows: A. Rescue Survival Assay
replicate 1, B. CFU Assay replicate 1, C. CFU Assay replicate 2 & Rescue Survival Assay
replicate 2, D. CFU Assay replicate 3, E. CFU Assay replicate 4.
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Table S1: Fungal CFU burdens used in experiments
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n= 51
n= 44
n= 44
n= 49

Figure S2 Macrophage Rac2 rescue survival assay replicates 1&2 combined. A.
Experimental design for achieving Rac2 expression in macrophages only. Wild-type control
group (Blue) corresponds to rac2 wild-type zebrafish larvae treated with a control morpholino
67

which does not inhibit translation of any gene mRNA transcript. The “rescue line” describes the
transgenic zebrafish line which expresses rac2 at an additional macrophage specific locus, and
produces an mRNA transcript which is not recognized by the rac2 morpholino used. This line
was treated with control morpholino to provide control for possible differences genetic
background in this transgenic line could have on survival of zebrafish (Green). Treatment of this
rescue line with the rac2 morpholino leads to macrophage specific expression of rac2 only
(Orange). Rac2 wild-type zebrafish were also treated with rac2 morpholino to serve as control
for the known/expected detrimental effects of total loss of rac2 expression on survival (red). B.
Survival assay results of 2 combined repliactes are shown, with a key corresponding to the
conditions outlined in S2A. A minimum of 3 replicates must performed for survival analysis thus
statistics are not reported here.
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Figure S3 Germination occurrences increase in both control and Rac2-/- zebrafish when
spore burden is increased. A. Previously shown example of germination. B. Occurrences of
germination in larvae for replicates 1-3, which consisted of zebrafish larvae with an average of
fewer than 20 A. fumigatus spores in the hindbrain region imaged. C. Occurrences of
germination in larvae for replicates 4-6, consisting of larvae with and average above 20 spores in
the hindbrain and no fewer than 20 (higher burden). D. Previously shown total merged data for
occurrences of germination in replicates 1-6.
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Figure S4 Live-dead reporter spore technique (Top left) GFP Channel, indicating presence of
spores expressing promoter driven GFP protein and indicating live spore presence. (Top right)
Spores expressing Alexafluor633 membrane tethered fluorophores, which are constitutively
active, indicating presence of spores. (Bottom left) Macrophage channel, to indicate spores
which are phagocytosed at time of imaging (Bottom right) Merged channels
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